Skip to content

Friend or Foe? How Autoimmune Diseases Affect Sepsis Recovery

Role of Autoimmune Diseases in Sepsis Outcomes - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/07/070398
Enrollment
82
Registered
2024-07-10
Start date
Unknown
Completion date
Unknown
Last updated
2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B999- Unspecified infectious disease

Interventions

Intervention1: Nil: Nil Control Intervention1: Patients with Sepsis Without Autoimmune Diseases (Control Group): Inclusion Criteria: 1. Age 18 years and above. 2. Absence of documented autoimmune dise

Sponsors

Kasturba Hospital Manipal
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Confirmed diagnoses of autoimmune diseases based on established diagnostic criteria (e.g., ACR/EULAR classification criteria). 2. Clinical diagnosis of sepsis according to the Sepsis-3 criteria (SOFA score increase = 2 points due to infection) during hospitalisation.

Exclusion criteria

Exclusion criteria: 1. Age below 18 years 2. Lack of documented autoimmune disease diagnoses 3. Immunocompromised conditions not associated with autoimmune diseases (e.g., HIV/AIDS, solid organ transplantation) 4. Pregnancy, due to potential confounding effects on sepsis outcomes. 5. Inability to comprehend the study objectives or provide informed consent due to language or cognitive limitations 6. Limited availability for follow-up assessments or intended treatment, including discharge against medical advice

Design outcomes

Primary

MeasureTime frame
Sepsis Severity: Assess the severity of sepsis using the Sequential Organ Failure Assessment (SOFA) scoreTimepoint: Baseline

Secondary

MeasureTime frame
Length of Hospital Stay: Evaluate the duration of hospitalisation for sepsis patients with autoimmune diseases in comparision to those without autoimmune diseases.Timepoint: Baseline;Mortality: Determine the mortality rate among patients with autoimmune diseases & sepsis in comparision to those without autoimmune diseases.Timepoint: Baseline;Treatment Responses: Evaluate the influence of immunosuppressive therapies & biologic agents on the clinical trajectories of sepsis-related outcomes in patients with concurrent autoimmune diseases in comparison to those without autoimmune diseasesTimepoint: Baseline

Countries

India

Contacts

Public ContactAdarsh

Kasturba medical college Manipal

ram.bhat@manipal.edu9945272251

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026